212192-83-1

Upstream product

• 100-39-0 benzyl bromide 
• 151669-30-6 ethyl 2,3-di-O-isopropylidene-1-thio-α-D-mannopyranoside 
• 316188-13-3 ethyl 6-O-[(tert-butyl)diphenylsilyl]-2,3-di-O-isopropylidene-1-thio-α-D-mannopyranoside 
• 316188-11-1 ethyl 6-O-[(tert-butyl)diphenylsilyl]-1-thio-α-D-mannopyranoside 
• 4163-65-9 per-O-acetyl-α-D-mannopyranose 
• 7296-15-3 alpha-D-mannopyranoside 
• 32934-24-0 S-ethyl 2,3,4,6-tetra-O-acetyl-1-deoxy-1-thio-α-D-mannopyranoside 
• 7473-36-1 ethyl 1-thio-α-D-mannopyranoside 

Downstream Products

• 187152-88-1 ethyl 4,6-di-O-benzyl-1-thio-α-D-mannopyranoside 
• 1339943-42-8 C₅₀H₆₂O₁₈ 
• 1339943-40-6 C₅₆H₇₆O₁₈Si 
• 129750-23-8 Ethyl 3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 
• 212192-85-3 ethyl-2,3,4,6-tetra-O-benzyl-1-thio-α-D-galactopyranosyl-(1 - 3)-2-O-acetyl-4,6-di-O-benzyl-1-thio-α-D-mannopyranoside 
• 212192-84-2 ethyl 2-O-acetyl-4,6-di-O-benzyl-1-thio-α-D-mannopyranoside 
• 316188-22-4 benzyl 2-O-benzoyl-4,6-O-benzylidene-3-O-[3-(ethyl 2,4,6-tri-O-benzyl-1-thio-α-D-mannopyranosid-3-O-yl)-1,3-dioxopropyl]-α-D-glucopyranoside 
• 316188-20-2 ethyl 2,4,6-tri-O-benzyl-3-O-[3-(tert-butoxy)-1,3-dioxopropyl]-1-thio-α-D-mannopyranoside 
• 316188-21-3 ethyl 2,4,6-tri-O-benzyl-3-O-(carboxyacetyl)-1-thio-α-D-mannopyranoside 
• 289057-12-1 ethyl 2,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 
• 220009-34-7 benzyl 2-O-benzoyl-6-O-benzyl-3-O-[4-(ethyl 2,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside-3-O-yl)-1,4-dioxobutyl]-α-D-glucopyranoside 
• 316188-18-8 benzyl 2-O-benzoyl-4,6-O-benzylidene-3-O-[4-(ethyl 2,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside-3-O-yl)-1,4-dioxobutyl]-α-D-glucopyranoside 

Relevant academic research and scientific papers

GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV

Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.

Prearranged glycosides. Part 12. Intramolecular mannosylations of glucose derivatives via prearranged glycosides

A series of prearranged glycosides 5, 17, 23, 28, 37, and 41, having a benzyl-protected 1-thiomannosyl donor linked through its positions 2, 3, 4, and 6 via succinate and malonate tethers, respectively, to positions 2, 3, and 6 of a benzyl glucopyranoside acceptor, were prepared by condensation of the respective mannosyl succinates and malonates with suitably protected benzyl glucopyranosides. The prearranged glycosides were intramolecularly coupled under various conditions to give the corresponding tethered (1 → 4)-linked disaccharides. The yields and anomer ratios of the products of these couplings were interpreted in terms of the thermodynamic stability of the resulting disaccharides. In the case of prearranged glycoside 17, having positions 3 of both the donor and the acceptor linked by a succinate tether, a strong dependence of the diastereoselectivity of the intramolecular glycosylation on the activation procedure was observed. All other cases did not show a significant dependence of the outcome of the anomeric configuration in intramolecular glycosylation on the activation procedure or the solvent.

Synthesis of a di- and a trisaccharide related to the antigen from Klebsiella type 43

Starting from D-galactose, D-mannose and D-glucose methyl α-D- galactopyranosyl-(1→3)-α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside and allyl β-D-mannopyranosyl-(1→4)-β-D-glucopyranosyl uronate were synthesised in a highly stereoselective manner.